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Abstract
Purpose: To assess the reproducibility of detection of osseous and extra-osseous metastases in cancer patients using 
whole-body diffusion-weighted imaging with background body signal suppression (WB-DWIBS).
Material and methods: A prospective study was conducted on 39 consecutive patients (21 females, 18 males; mean 
age 48 years) with metastases, who underwent WB-DWIBS on a 1.5-T MR scanner. Image analysis was performed 
independently by two blinded observers. Inter-observer agreement was assessed for the detection of osseous (spinal, 
appendicular) and extra-osseous (hepatic, pulmonary, nodal, and peritoneal) metastases. 
Results: The overall inter-observer agreement of WB-DWIBS in the detection of osseous and extra-osseous metas-
tases was excellent (k = 0.887, agreement = 94.44%, p = 0.001). There was excellent inter-observer agreement of 
both observers for the detection of osseous spinal (k = 0.846, agreement = 92.3%), osseous appendicular (k = 0.898, 
agreement = 94.8 %), hepatic (k = 0.847, agreement = 92.3%), pulmonary (k = 0.938, agreement = 97.4%), nodal 
metastases (k = 0.856, agreement = 94.9%), and peritoneal metastasis (k = 0.772, agreement = 94.9%).
Conclusion: We concluded that WB-DWIBS is reproducible for detection of osseous and extra-osseous metastases in 
cancer patients.
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Introduction
Early detection of metastasis in cancer patients is an essen-
tial step for timely management and a positive outcome. 
Osseous metastasis can be spinal or appendicular and 
extra-osseous metastasis can involve the liver, lung, and 
lymph nodes [1-4]. Different imaging modalities are used 
for the detection of osseous and extra-osseous metastasis. 
Imaging modalities used for staging of cancer patients vary 
according to the local availability and expertise. Osseous 
metastases are screened for by whole-body imaging. They 
are not ruled out by various modalities because of false 
negatives and poor sensitivity of some studies [3-5]. Pos-
itron-emission computed tomography (PET-CT) is the 
method of choice because of its sensitivity; however, it is 
expensive and not available in most centres [5]. CT scans 
of the chest, abdomen, and pelvis are commonly used for 
assessment of extra-osseous metastasis, but they are asso-
ciated with radiation exposure [6-8].
Diffusion-weighted imaging could be readily added 
to conventional imaging and adds valuable functional 
information about tumour cellularity. The rationale for 
use of diffusion-weighted imaging is that malignant tu-
mours have higher cellular density than normal tissue 
and show restricted diffusion. Diffusion-weighted mag-
netic resonance (MR) imaging used in the assessment 
of osseous and other lesions such as liver, breast, chest 
tumours, and bony and soft tissue [9-12]. Recently there 
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has been growing interest in the use of whole-body MR 
imaging with diffusion-weighted imaging for detection 
of metastases [11,12]. The introduction of diffusion- 
weighted imaging with background body signal suppres-
sion (DWIBS) technique has greatly improved whole-
body MR imaging [11-14]. Few studies have addressed 
the potential role of whole-body diffusion-weighted 
imaging (WB-DWI) with background body signal sup-
pression for the detection of osseous metastases in can-
cer staging [15-21]. Good inter-observer agreement of 
this technique is a prerequisite for its widespread clinical 
application. A unique aspect of this study is that we have 
assessed the osseous and extra-osseous metastases in can-
cer patients in the same work.
This prospective study was performed to assess the 
inter-observer agreement of WB-DWIBS for the detec-




The institutional review board approved this study and in-
formed consent was taken from each patient beforehand. 
This prospective study included 42 patients with patho-
logically proven primary malignant tumours and clinical-
ly suspected or known metastases. We excluded three pa-
tients from the study, due to claustrophobia in two patients 
and inadequate image quality in one patient due to mo-
tion artefacts. The final participants comprised 39 patients 
(21 females, 18 males; mean age 48 years). The primary 
malignant tumours were prostate cancer (n = 14), breast 
cancer (n = 12), colon cancer (n = 10), and pelvic cancer 
(n = 3). All patients underwent whole-body MR imaging 
using whole-body short tau inversion recovery (WB-STIR) 
and WB-DWIBS.
Magnetic resonance imaging technique
Whole-body MR imaging was performed using a 1.5-Tesla 
MR scanner (Ingenia, Philips healthcare, Best, Nether-
lands), using a table moving technique. Integrated body 
coils were used, and images were acquired in the coro-
nal plane. Patients were examined in the supine feet-first 
position on a rolling table plate. Positioning of the up-
per extremities was according to the patient’s habitus. In 
cachectic patients, the arms were easily placed over the 
thorax and abdomen. In larger patients, the arms were 
placed above the head, requiring an additional coronal 
acquisition and additional four minutes of scan time. 
At first, three-plane localiser scout views were per-
formed for the region of interest. The WB-STIR and 
WB-DWIBS were done in coronal plane for five separate 
regions: 1 – head, neck, chest apex, proximal upper limb, 
and cervical spine; 2 – chest, upper abdomen, upper limb, 
dorsal, and upper lumbar spine; 3 – lower abdomen and 
upper pelvis; 4 – lower pelvis and thighs; 5 – distal femur, 
knee joint, and proximal tibia. By the combination of the 
moving tabletop, table extender, and image-melding soft-
ware the scan time was about 30-35 min. 
The parameters of WB-STIR were: repetition time 
(TR) = 3000-5000 ms; echo time (TE) = 70 ms; inver-
sion time (TI) =165 ms; slice thickness = 6 mm; field 
of vein (FOV) = 300-360 mm and matrix = 256 x 256. 
The WB-DWIBS was done using no-EPI diffusion-weight-
ed technique with free breathing. The parameters of WB-
DWIBS were: TR = 7410 ms, TE = 60 ms, TI = 165 ms, 
slice thickness = 3 mm, B-value = 400-800 s/mm2, matrix 
= 256 × 256, and FOV = 250 mm.
Image analysis
Post processing was performed offline to produce whole-
body images using a Philips workstation with commer-
cially available software. Two radiologists fully blinded to 
the clinical data and results of other diagnostic imaging 
modalities independently analysed the WB-DWIBS image 
sequence. Image interpretation was directed at detection 
of osseous and extra-osseous metastases. On WB-DWIBS 
images, each site of abnormal or focal increase of signal 
intensity not from normal anatomic structure or with an 
unexpected increase of signal intensity was considered as 
positive for metastases. 
Reference standard
The standard of reference was biopsy with histopatho-
logical examination for nodal sampling (n = 12), hepatic 
focal lesions (n = 10), pulmonary nodules (n = 7) and. 
For verification of the other bony and extra-bony lesions 
detected at WB-DWIBS, a combined reference stand-
ard was used including the clinical follow-up data with 
a mean follow-up period of 6.2 ± 1.2 months for all pa-
tients, as well as progression or regression of the metastat-
ic foci in response to the therapy at follow-up CT. 
Statistical analysis
The statistical analysis of data was done using the Statistical 
Package for Social Science, version 22 (SPSS Inc., Chicago, 
IL, USA). The inter-observer agreement was assessed by kap-
pa (k) statistic with 95% confidence intervals (CI); a p val-
ue < 0.05 was considered to indicate statistical significance. 
The k coefficient is the amount of observed agreement. A k of 
1.0 represents perfect agreement, a k of 0.81 to 1.0 is excellent 
agreement, and a k of 0.61 to 0.80 is good agreement.
Results
Table 1 shows inter-observer agreement of WB-DWIBS 
in the detection of osseous and extra-osseous metastatic 
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deposits in cancer patients. The overall inter-observer 
agreement of WB-DWIBS in the detection of metastases 
was excellent (k = 0.887, agreement = 94.44%).
The overall inter-observer agreement of WB-DWIBS in 
the detection of osseous metastases was excellent (k = 0.872, 
agreement = 93.6%). Osseous spinal metastases (Figure 1) 
were reported in 18 patients by observer 1 and 19 patients 
by observer 2, with an excellent agreement (k = 0.846, 
agreement = 92.3%). Osseous appendicular metastases 
(Figure 1) were reported in 20 patients by observer 1 and 
18 patients by observer 2, with an excellent agreement 
(k = 0.898, agreement = 94.8%). 
The overall inter-observer agreement of WB-DWIBS 
in the detection of extra-osseous metastases was excellent 
(k = 0.895, agreement = 94.9%). Hepatic metastases (Fig-
ure 2) were reported in 18 patients by observer 1 and 21 
patients by observer 2, with excellent agreement (k = 0.847, 
agreement = 92.3%). Pulmonary metastases were reported 
in 12 patients by observer 1 and 11 patients by observer 2, 
with excellent agreement (k = 0.938, agreement = 97.4%). 
Nodal metastases (Figure 3) were reported in 31 patients 
by observer 1 and in 29 patients by observer 2, with excel-
Table 1. Inter-observer agreement of whole-body diffusion-weighted imaging with background body signal suppression (WB-DWIBS) in detection 
of osseous and extra-osseous metastases
Metastases Observer 1 Observer 2 Percentage agreement k 95% CI p value
Osseous 38 37 93.6% 0.872 0.76-0.98 0.001
Spinal 18 19 92.3% 0.846 0.68-1.0 0.001
Appendicular 20 18 94.8% 0.898 0.76-1.0 0.001
Extra-osseous 67 65 94.9% 0.895 0.82-0.97 0.001
Hepatic 18 21 92.3% 0.847 0.68-1.0 0.001
Pulmonary 12 11 97.4% 0.938 0.82-1.0 0.001
Nodal 31 29 94.9% 0.856 0.66-1.0 0.001
Peritoneal 6 4 94.9% 0.772 0.50-1.0 0.001
Overall 105 102 94.44% 0.887 0.83-0.94 0.001
Figure 1. Spinal and appendicular metastases from breast cancer: A) Whole- 
body short tau inversion recovery image shows multiple well-defined 
hyper-intense lesions seen in both femori and the spine. B) Whole-body 
diffusion-weighted imaging with background body signal suppression 
image shows better evaluation of osseous metastasis in the spine, both 
femurs, left scapula, and ribs with restricted diffusion of the lesion
A B A B
Figure 2. Hepatic metastases from colon cancer. A) Whole-body short tau 
inversion recovery image shows multiple hyper-intense focal lesions of the 
liver. B) Whole-body diffusion-weighted imaging with background body sig-
nal suppression image shows multiple focal lesions of the liver with restricted 
diffusion
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lent agreement (k = 0.856, agreement = 94.9%). Peritoneal 
metastases were reported in six patients by observer 1 and 
in four patients by observer 2, with excellent agreement 
(k = 0.772, agreement = 94.9%).
Discussion
The main finding in this study is that there is excellent 
inter-observer agreement of WB-DWIBS (k = 0.887) in the 
overall detection of metastases, including osseous spinal 
or appendicular metastases as well as extra-osseous me-
tastases, whether hepatic, pulmonary, nodal, or peritoneal.
There are several studies that have compared WB-MRI 
to skeletal scintigraphy for the detection of osseous me-
tastases, with encouraging results about the performance 
of WB-MRI. In a study by Stecco et al., the accuracy of 
WB-DWIBS was similar to scintigraphy, with excellent 
agreement between the two methods [22]. Gutzeit et al. 
reported that WB-DWIBS detected more metastases 
than scintigraphy in patients with large numbers of le-
sions [23]. Lecouvet et al. reported that the performance 
of WB-DWIBS is better than scintigraphy in the detection 
of osseous metastases in patients with high-risk prostate 
cancer [24]. Similarly, the diagnostic accuracy of WB-MRI 
for detection of bone metastases was significantly higher 
than skeletal scintigraphy [25].
In this study, the inter-observer agreement of WB-
DWIBS in the detection of spinal and appendicular osseous 
metastases is excellent (k = 0.846 and 0.898, respectively). 
Balliu et al. reported excellent agreement (k = 0.895) for 
WB-MRI in metastases detection [25]. On the other hand, 
earlier studies reported that the inter-observer agreement of 
WB-DWIBS is good (k = 0.66, 0.68) [22-33].
In this study, there was excellent inter-observer agree-
ment in the detection of hepatic (k = 0.847) and pulmo-
nary (k = 0.938) metastases, and good agreement for 
peritoneal (k = 0.772) metastases. Stecco et al. reported 
excellent agreement (k = 0.93) between two observers us-
ing WB-DWIBS in the staging of oncologic patients [15]. 
One study reported that the accuracy of WB-DWI for the 
detection of pulmonary metastases is only 60% compared 
to 100% for conventional CT [26]. Another study report-
ed that the sensitivity of WB-DWIBS for the detection of 
pulmonary metastases is lower than that of CT (51.6% vs. 
71.4%, respectively) [27].
In this study, the agreement between both observers 
for nodal metastasis was excellent (k = 0.856). Visual as-
sessment by WB-DWIBS is well suited for the detection 
of lymph nodes because of the cellularity of nodes in con-
trast to the suppressed signal of the surrounding fat [14]. 
One study reported that WB-DWIBS has the same diag-
nostic performance as combined CT, PET-CT, and lymph 
node ultrasonography in the detection of nodal metasta-
ses [27]. Diffusion characteristics should be supplemented 
by morphological data of the size and shape criteria of 
the lymph node. Few studies discuss the value of apparent 
diffusion coefficient (ADC) measurements for the identi-
fication of nodal metastases. These studies reported that 
malignant lymph nodes reported restricted diffusion with 
lower ADC values the than benign nodes [28-34]. 
The implementation of WB-DWIBS in whole-body 
imaging has many advantages. This technique allowed 
shorter interpretation time and easy visual assessment 
with reconstructed multi-planar images. This technique 
uses free breathing and therefore enables thin axial sec-
tion acquisition and multiple signal averaging, in addition 
to fat-suppression, which further highlights regions of dif-
fusion restriction [14-17]. Previous studies demonstrated 
the high accuracy of WB-DWIBS in the staging of cancer 
patients in comparison to positron-emission computed 
tomography [15, 17, 19]. WB-DWIBS has a great potential 
for whole-body imaging of oncologic patients, being faster 
and more convenient for patients than undergoing mul-
tiple imaging sessions for staging, with substantial cost 
Figure 3. Nodal metastases from breast cancer after mastectomy. A) Whole-
body short tau inversion recovery image shows well-defined hyper-intense 
left-sided axillary lymph nodes. B, C) Whole-body diffusion-weighted im-
aging with background body signal suppression shows restricted diffusion 
of the left axillary lymph nodes
BA C
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and time savings [2-4]. The lack of radiation and injection 
of contrast medium or isotope make WB-DWIBS well 
suited for screening [11-14].
The ability of WB-DWIBS for metastases detection 
is variable and is affected by many factors including the 
histological type and grade of the tumour as well as the 
anatomic location of the target lesions. False negative re-
sults may also be seen with tumours located in sites af-
fected by motion that causes decreased signal, such as the 
lung hila, mediastinum, or the uppermost part of the left 
hepatic lobe [12-15]. Susceptibility artefacts represent an-
other challenge that may degrade image quality and mask 
lesions, leading to false negative results [11]. False positive 
results may be obtained due to the so-called “T2-shine 
through” effect, where lesions with high T2 signal may be 
mistaken for areas of restricted diffusion [1-4]. 
There are a few limitations of this study. First, the 
number of patients is relatively small. Further studies on 
a larger cohort are encouraged. Second, we admit patients 
have been not examined by PET/CT. Further studies are 
recommended to correlate osseous and extra-osseous 
lesions detected at WB-DWIBS with PET-CT findings. 
Third, this study applies diffusion-weighted imaging on 
1.5-Tesla scanners. Further studies applied to diffusion 
tensor imaging combined with other sequences of MR 
such as arterial spin labelling on higher 3-Tesla scanners 
will improve the results in the future [35-46]. 
Conclusions
We conclude that the WB-DWIBS technique is reproduc-
ible for the detection of osseous and extra-osseous metas-
tases in cancer patients. 
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